[Extended-spectrum beta-lactamase producing-enterobacteriaceae]. 2012

P Mariani-Kurkdjian, and C Doit, and E Bingen
CNR associé E. coli-Shigella, Service de Microbiologie, Université Paris-Diderot, Hôpital Robert Debré, 48, boulevard Sérurier, 75935 Paris cedex 19, France.

Extended-spectrum beta-lactamase (ESBLs) are defined as ß-lactamase able to hydrolyze all penicillins and cephalosporins with the exception of cephamycins (cefotixin, cefotetan), moxalactam and carbapenems and are encoded by mobile genes. The most frequently encountered ESBLs belong to the CTX-M, SHV, and TEM families. ESBLs were found first in Klebsiella pneumonia and then predominantly in E. coli. The incidence of patients with ESBLs E. coli increase since 2000 in Robert Debré Hospital in Paris. They were mainly implicated in urinary tract infections and less frequently in other infections such as materno-foetal infections or neonatal meningitis. An increase of consumption of carbapenems may lead to spread of carbapenem resistant organisms. Thus alternative to carbapenems for treatment of ESBL producers are needed.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D004756 Enterobacteriaceae Infections Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

P Mariani-Kurkdjian, and C Doit, and E Bingen
May 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
P Mariani-Kurkdjian, and C Doit, and E Bingen
July 2005, Journal of clinical microbiology,
P Mariani-Kurkdjian, and C Doit, and E Bingen
May 2006, Emerging infectious diseases,
P Mariani-Kurkdjian, and C Doit, and E Bingen
October 2021, Foods (Basel, Switzerland),
P Mariani-Kurkdjian, and C Doit, and E Bingen
July 2005, The New Zealand medical journal,
P Mariani-Kurkdjian, and C Doit, and E Bingen
June 2008, Microbial drug resistance (Larchmont, N.Y.),
P Mariani-Kurkdjian, and C Doit, and E Bingen
January 2002, Roumanian archives of microbiology and immunology,
P Mariani-Kurkdjian, and C Doit, and E Bingen
January 2009, Journal of infection and public health,
P Mariani-Kurkdjian, and C Doit, and E Bingen
June 2015, The Journal of hospital infection,
P Mariani-Kurkdjian, and C Doit, and E Bingen
March 2009, Emerging infectious diseases,
Copied contents to your clipboard!